IMCC imcannabis.com Quarterly EPS earnings growth

Brandmark of imcannabis.com (IMCC)

IM Cannabis Corp. supplies premium medical cannabis to pharmacies in Europe and Israel, adhering to strict EU standards. The quarterly EPS change scale provided by the GURU.Markets system helps identify demand imbalances, while 55.70 expresses the current value of the metric. The company is implementing innovative processing methods to standardize product quality. Licensed hubs in Canada and Israel ensure seamless international logistics.

IM Cannabis Corp (IMCC) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company imcannabis.com (IMCC)

- market value and analyst target forecast:
Initial company analysis:IM Cannabis Corp.
Flagship merchandise of IM Cannabis Corp.

Complex regulations in the German and Israeli markets create high entry costs for IM Cannabis Corp. (IMCC), transforming licensing barriers into a strategic asset. Quarterly EPS dynamics reflect the rate of change in net income per share, allowing investors to assess the actual efficiency of monetizing these advantages by analyzing the quarterly EPS history to identify a sustainable profitability trend.

Key competitors

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc)|Skye Bioscience (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Anebulo Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months InterCure|NTRB: Quarterly EPS earnings growth|NSRX - Year-over-year net earnings per share change for the last twelve months|IGC (IGC Pharma Inc) - Quarterly EPS earnings growth|MIRA Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth FLGC|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)